Plain-English translation of NCT06856213 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial tests whether adding weekly (a chemotherapy drug) to (a targeted therapy) works better than alone for people with head and neck cancer that has progressed despite first-line immunotherapy. Both groups receive the same starting treatments but differ in whether chemotherapy is included in the early phase of care.
Many patients with advanced head and neck cancer stop responding to initial immunotherapy and chemotherapy combinations. Researchers need to find better treatment options for these patients, and this study compares two approaches using —a targeted drug that attacks cancer cells differently—to see which gives the best results.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either plus or alone. During the first phase, you'll receive infusions on a set schedule over three-week cycles for four cycles, then continue with maintenance treatment ( infusions every two weeks) until your disease progresses or side effects become too severe. You'll have regular clinic visits, blood tests, imaging scans, and tumor biopsies to assess how well the treatment is working and to monitor your health and quality of life throughout the study.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Spain